Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
about
Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian periodSingle-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sitesInduction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.Sequence dependent modulating effect of camptothecin on the DNA-cleaving activity of the calf thymus type I topoisomerase.The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replicationIdentification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sitesCancer therapies utilizing the camptothecins: a review of the in vivo literatureSequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.RGD-mediated delivery of small-molecule drugs.DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin.Sequence-selective DNA cleavage by a topoisomerase I poison, NB-506.DNA cleavage assay for the identification of topoisomerase I inhibitors.
P2860
Q24297026-C9219063-687F-42E7-9D56-0CEEC9DFE7DCQ30673594-AC088686-A715-4E2C-A7F6-870F4398DBE9Q33932878-6CB8D2BC-E6B4-40C0-B2D3-A926D08E2DF2Q35020099-A6141F40-D0BC-43E3-A93C-3C270090D612Q35047219-B3D8EA78-A12F-401F-BBC1-6E84C5622734Q35833642-CDB4537F-4D95-48D8-AB8C-83580CE620F6Q35908020-1846EE07-7AAC-4A0E-85FB-05E357762FA3Q35952975-49F3FCF1-BA71-4FC8-8297-7F1636051E1AQ36798342-280045F2-7ED8-409A-9AE6-DAE891F621DAQ36799774-9219FF97-FB67-46E4-9D4B-FBB87944906CQ37069556-CF4ABEF7-116B-4BB5-AF1C-8CAE7100097EQ37528750-CE8941F3-58E4-4128-80EA-9F8233CD6E05Q37564077-87FA0815-A8F6-4376-AE7B-3DB3ECAA36ECQ38732486-93353AC3-1A94-4DF5-8F77-C059989CCB77Q42623345-E6C0B8D9-8E5A-444C-B444-53D8F68B4BECQ42670541-CBB62C42-451B-49C2-B0EC-471017711035Q46312378-6D82DA8D-8E0D-4EEC-B247-A07837211C2C
P2860
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@ast
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@en
type
label
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@ast
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@en
prefLabel
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@ast
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@en
P2093
P2860
P356
P1476
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
@en
P2093
P2860
P304
11157-11170
P356
10.1093/NAR/16.23.11157
P407
P577
1988-12-01T00:00:00Z